NL7002463A - - Google Patents
Info
- Publication number
- NL7002463A NL7002463A NL7002463A NL7002463A NL7002463A NL 7002463 A NL7002463 A NL 7002463A NL 7002463 A NL7002463 A NL 7002463A NL 7002463 A NL7002463 A NL 7002463A NL 7002463 A NL7002463 A NL 7002463A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80345869A | 1969-02-28 | 1969-02-28 | |
| US814270A | 1970-01-19 | 1970-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7002463A true NL7002463A (enExample) | 1970-09-01 |
Family
ID=26677851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7002463A NL7002463A (enExample) | 1969-02-28 | 1970-02-20 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US3538104A (enExample) |
| AT (1) | AT290529B (enExample) |
| BE (1) | BE746656A (enExample) |
| CH (1) | CH526566A (enExample) |
| DE (1) | DE2009408A1 (enExample) |
| FR (1) | FR2034575B1 (enExample) |
| GB (1) | GB1305273A (enExample) |
| NL (1) | NL7002463A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH561202A5 (enExample) * | 1971-05-10 | 1975-04-30 | Ciba Geigy Ag | |
| US4405628A (en) * | 1981-03-05 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Pyridylimidazolones and method of use |
| US4532250A (en) * | 1983-11-23 | 1985-07-30 | American Hospital Supply Corporation | 5-Heteroarylimidazol-2-ones having cardiotonic activity |
| US4728661A (en) * | 1985-11-13 | 1988-03-01 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic phenyl oxazolones |
| US4698353A (en) * | 1985-11-13 | 1987-10-06 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic heterocyclic oxazolones |
| US4670450A (en) * | 1985-11-13 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic thiazolones |
| US4911753A (en) * | 1987-01-21 | 1990-03-27 | American Cyanamid Company | Herbicidal 2-(2-imidazolin-2-yl)fluoroalkoxy-, alkenyloxy-, and alkynyloxypyridines and quinolines |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| AU2004201666C1 (en) * | 2001-10-22 | 2006-10-12 | Tanabe Seiyaku Co., Ltd. | 4-Imidazolin-2-one compounds |
| US7473695B2 (en) * | 2001-10-22 | 2009-01-06 | Mitsubishi Tanabe Pharma Corporation | 4-imidazolin-2-one compounds |
| MXPA04003729A (es) | 2001-10-22 | 2004-07-23 | Tanabe Seiyaku Co | Compuestos de 4-imidazolin-2-ona. |
| ES2362877T3 (es) * | 2003-04-21 | 2011-07-14 | Mitsubishi Tanabe Pharma Corporation | Compuestos de imidazolin-2-ona. |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置 |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
-
1969
- 1969-02-28 US US803458*A patent/US3538104A/en not_active Expired - Lifetime
-
1970
- 1970-01-19 US US8142A patent/US3678169A/en not_active Expired - Lifetime
- 1970-02-20 NL NL7002463A patent/NL7002463A/xx unknown
- 1970-02-26 CH CH277770A patent/CH526566A/de not_active IP Right Cessation
- 1970-02-27 AT AT182170A patent/AT290529B/de not_active IP Right Cessation
- 1970-02-27 GB GB956370A patent/GB1305273A/en not_active Expired
- 1970-02-27 BE BE746656D patent/BE746656A/xx unknown
- 1970-02-27 DE DE19702009408 patent/DE2009408A1/de active Pending
- 1970-02-27 FR FR707007168A patent/FR2034575B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AT290529B (de) | 1971-06-11 |
| US3538104A (en) | 1970-11-03 |
| BE746656A (fr) | 1970-08-27 |
| US3678169A (en) | 1972-07-18 |
| DE2009408A1 (de) | 1970-09-17 |
| FR2034575A1 (enExample) | 1970-12-11 |
| FR2034575B1 (enExample) | 1973-07-13 |
| CH526566A (de) | 1972-08-15 |
| GB1305273A (enExample) | 1973-01-31 |